Cipla Limited (BOM:500087)

Market Cap	1.08T -4.6%
Revenue (ttm)	279.67B +4.7%
Net Income	45.46B -8.9%
EPS	56.25 -8.9%
Shares Out	n/a
PE Ratio	23.66
Forward PE	23.95
Dividend	16.00 (1.19%)
Ex-Dividend Date	Jun 27, 2025

Volume	19,472
Average Volume	100,509
Open	1,326.05
Previous Close	1,329.55
Day's Range	1,315.90 - 1,335.10
52-Week Range	1,283.00 - 1,672.20
Beta	n/a
RSI	35.35
Earnings Date	Jan 23, 2026

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 30,313
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500087

Financial Performance

In fiscal year 2025, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.